| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics, Inc. | Wills Robert James | Director | Apr 08, 2024 | Buy | $8.96 | 3,086 | 27,655 | 10,000 | Apr 10, 2024, 08:38 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Wills Robert James | Director | Mar 28, 2024 | Buy | $8.48 | 6,914 | 58,602 | 6,914 | Apr 01, 2024, 07:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | HALE DAVID F | Director | Feb 23, 2024 | Buy | $9.04 | 714 | 6,455 | 714 | Feb 27, 2024, 05:03 PM | |
| ONCT | Oncternal Therapeutics, Inc. | HALE DAVID F | Director | Feb 23, 2024 | Buy | $9.04 | 266 | 2,405 | 29,673 | Feb 27, 2024, 05:03 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Wills Robert James | Director | Feb 23, 2024 | Sale | $9.04 | 980 | 8,859 | 0 | Feb 27, 2024, 05:02 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Krishnan Rajesh | Chief Technical Officer | Jan 03, 2024 | Option Exercise | $0.50 | 11,838 | 5,873 | 44,019 | Jan 05, 2024, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Yazji Salim | Chief Medical Officer | Jan 03, 2024 | Option Exercise | $0.50 | 19,742 | 9,794 | 128,635 | Jan 05, 2024, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | VINCENT RICHARD G | Chief Financial Officer | Jan 03, 2024 | Option Exercise | $0.50 | 8,868 | 4,399 | 140,922 | Jan 05, 2024, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Jan 03, 2024 | Option Exercise | $0.50 | 11,838 | 5,873 | 84,758 | Jan 05, 2024, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | BREITMEYER JAMES B | Chief Executive Officer | Jan 03, 2024 | Option Exercise | $0.50 | 50,955 | 25,279 | 443,034 | Jan 05, 2024, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | BREITMEYER JAMES B | Chief Executive Officer | Jan 03, 2024 | Option Exercise | $0.50 | 4,485 | 2,225 | 15,426 | Jan 05, 2024, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | BREITMEYER JAMES B | Chief Executive Officer | Jul 03, 2023 | Option Exercise | $0.36 | 47,992 | 17,277 | 493,989 | Jul 05, 2023, 06:59 PM | |
| ONCT | Oncternal Therapeutics, Inc. | BREITMEYER JAMES B | Chief Executive Officer | Jul 03, 2023 | Option Exercise | $0.36 | 4,007 | 1,443 | 19,911 | Jul 05, 2023, 06:59 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Jul 03, 2023 | Option Exercise | $0.36 | 10,305 | 3,710 | 96,596 | Jul 05, 2023, 06:59 PM | |
| ONCT | Oncternal Therapeutics, Inc. | VINCENT RICHARD G | Chief Financial Officer | Jul 03, 2023 | Option Exercise | $0.36 | 7,069 | 2,545 | 149,790 | Jul 05, 2023, 06:58 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Yazji Salim | Chief Medical Officer | Jul 03, 2023 | Option Exercise | $0.36 | 16,299 | 5,868 | 148,377 | Jul 05, 2023, 06:58 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Krishnan Rajesh | Chief Technology Officer | Jul 03, 2023 | Option Exercise | $0.36 | 10,897 | 3,923 | 55,857 | Jul 05, 2023, 06:57 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Kaufmann Gunnar F. | Chief Scientific Officer | Jun 12, 2023 | Buy | $0.35 | 25,000 | 8,745 | 91,726 | Jun 14, 2023, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Kaufmann Gunnar F. | Chief Scientific Officer | Jun 14, 2023 | Buy | $0.36 | 3,000 | 1,079 | 94,726 | Jun 14, 2023, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | BREITMEYER JAMES B | Chief Executive Officer | Apr 13, 2023 | Buy | $0.29 | 100,000 | 29,000 | 146,544 | Apr 17, 2023, 06:00 AM | |
| ONCT | Oncternal Therapeutics, Inc. | BREITMEYER JAMES B | Chief Executive Officer | Apr 14, 2023 | Buy | $0.30 | 50,000 | 14,930 | 196,544 | Apr 17, 2023, 06:00 AM | |
| ONCT | Oncternal Therapeutics, Inc. | Yazji Salim | Chief Medical Officer | Apr 12, 2023 | Buy | $0.28 | 10,000 | 2,850 | 149,676 | Apr 14, 2023, 06:02 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Yazji Salim | Chief Medical Officer | Apr 13, 2023 | Buy | $0.28 | 10,000 | 2,850 | 159,676 | Apr 14, 2023, 06:02 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Yazji Salim | Chief Medical Officer | Apr 14, 2023 | Buy | $0.30 | 5,000 | 1,500 | 164,676 | Apr 14, 2023, 06:02 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Apr 12, 2023 | Buy | $0.29 | 15,000 | 4,350 | 96,901 | Apr 14, 2023, 06:00 AM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Apr 13, 2023 | Buy | $0.29 | 10,000 | 2,900 | 106,901 | Apr 14, 2023, 06:00 AM | |
| ONCT | Oncternal Therapeutics, Inc. | VINCENT RICHARD G | Chief Financial Officer | Apr 13, 2023 | Buy | $0.30 | 30,000 | 8,961 | 156,859 | Apr 14, 2023, 06:00 AM | |
| ONCT | Oncternal Therapeutics, Inc. | Krishnan Rajesh | Chief Technology Officer | Jan 03, 2023 | Option Exercise | $1.02 | 6,238 | 6,363 | 66,754 | Jan 05, 2023, 06:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | BREITMEYER JAMES B | Chief Executive Officer | Jan 03, 2023 | Option Exercise | $1.02 | 27,793 | 28,349 | 541,981 | Jan 05, 2023, 06:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | BREITMEYER JAMES B | Chief Executive Officer | Jan 03, 2023 | Option Exercise | $1.02 | 1,325 | 1,351 | 23,918 | Jan 05, 2023, 06:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Jan 03, 2023 | Option Exercise | $1.02 | 6,091 | 6,213 | 81,901 | Jan 05, 2023, 06:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Kaufmann Gunnar F. | Chief Scientific Officer | Jan 03, 2023 | Option Exercise | $1.02 | 6,266 | 6,391 | 66,726 | Jan 05, 2023, 06:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Yazji Salim | Chief Medical Officer | Jan 03, 2023 | Option Exercise | $1.02 | 9,961 | 10,160 | 139,676 | Jan 05, 2023, 06:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | VINCENT RICHARD G | Chief Financial Officer | Jan 03, 2023 | Option Exercise | $1.02 | 4,428 | 4,517 | 126,859 | Jan 05, 2023, 06:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | VINCENT RICHARD G | Chief Financial Officer | Mar 24, 2022 | Buy | $1.45 | 3 | 4 | 83,165 | Mar 28, 2022, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | VINCENT RICHARD G | Chief Financial Officer | Mar 25, 2022 | Buy | $1.48 | 2,497 | 3,706 | 85,662 | Mar 28, 2022, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | VINCENT RICHARD G | Chief Financial Officer | Mar 28, 2022 | Buy | $1.40 | 2,500 | 3,500 | 88,162 | Mar 28, 2022, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | VINCENT RICHARD G | Chief Financial Officer | Jan 27, 2022 | Buy | $1.75 | 10,000 | 17,500 | 80,662 | Jan 31, 2022, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | VINCENT RICHARD G | Chief Financial Officer | Jan 28, 2022 | Buy | $1.65 | 2,500 | 4,125 | 83,162 | Jan 31, 2022, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Jan 27, 2022 | Buy | $1.78 | 8,500 | 15,130 | 39,867 | Jan 31, 2022, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Jan 28, 2022 | Buy | $1.63 | 5,000 | 8,150 | 44,867 | Jan 31, 2022, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Yazji Salim | Chief Medical Officer | Jan 27, 2022 | Buy | $1.69 | 10,000 | 16,900 | 67,137 | Jan 31, 2022, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | BREITMEYER JAMES B | Chief Executive Officer | Jan 27, 2022 | Buy | $1.68 | 25,000 | 42,080 | 46,544 | Jan 31, 2022, 04:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | HALE DAVID F | Director | Jun 30, 2021 | Sale | $4.75 | 3,669 | 17,428 | 713,152 | Jul 02, 2021, 05:01 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Leavitt Chase C. | General Counsel/Secretary | Jun 11, 2021 | Buy | $5.45 | 1,500 | 8,175 | 1,500 | Jun 15, 2021, 06:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | CARTER MICHAEL G | Director | Sep 01, 2020 | Buy | $2.10 | 71,429 | 150,001 | 71,947 | Sep 02, 2020, 04:53 PM | |
| ONCT | Oncternal Therapeutics, Inc. | KISNER DANIEL L | Director | Jul 21, 2020 | Buy | $2.38 | 10,000 | 23,825 | 10,000 | Jul 23, 2020, 05:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | AKER HAZEL M | Legal Counsel | Jul 21, 2020 | Buy | $2.38 | 41,972 | 99,998 | 46,987 | Jul 23, 2020, 05:00 PM | |
| ONCT | Oncternal Therapeutics, Inc. | Shanghai Pharmaceuticals Holding Co., Ltd. | 10% Owner | Jul 21, 2020 | Buy | $2.38 | 1,049,317 | 2,499,998 | 3,544,431 | Jul 23, 2020, 04:32 PM | |
| GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Jan 02, 2019 | Option Exercise | $0.86 | 18,169 | 15,625 | 4,207,368 | Jan 03, 2019, 04:27 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Jan 02, 2019 | Option Exercise | $0.86 | 14,535 | 12,500 | 36,759 | Jan 03, 2019, 04:27 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Oct 01, 2018 | Option Exercise | $1.50 | 8,333 | 12,500 | 22,224 | Oct 02, 2018, 05:02 PM | |
| GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Oct 01, 2018 | Option Exercise | $1.50 | 8,917 | 13,376 | 44,105 | Oct 02, 2018, 05:01 PM | |
| GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Oct 01, 2018 | Option Exercise | $1.50 | 10,417 | 15,626 | 1,939,199 | Oct 02, 2018, 05:01 PM | |
| GTXI | GTX INC /DE/ | Young Diane C. | VP, Chief Medical Officer | Jul 16, 2018 | Sale | $14.70 | 2,049 | 30,120 | 45,936 | Jul 17, 2018, 05:49 PM | |
| GTXI | GTX INC /DE/ | Young Diane C. | VP, Chief Medical Officer | Jul 13, 2018 | Option Exercise | $14.92 | 2,014 | 30,049 | 47,985 | Jul 17, 2018, 05:49 PM | |
| GTXI | GTX INC /DE/ | Young Diane C. | VP, Chief Medical Officer | Jul 13, 2018 | Option Exercise | $14.92 | 2,014 | 30,049 | 47,985 | Jul 17, 2018, 05:03 PM | |
| GTXI | GTX INC /DE/ | Young Diane C. | VP, Chief Medical Officer | Jul 16, 2018 | Sale | $14.70 | 2,049 | 30,120 | 45,936 | Jul 17, 2018, 05:03 PM | |
| GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Jul 02, 2018 | Option Exercise | $15.47 | 865 | 13,382 | 35,189 | Jul 03, 2018, 11:08 AM | |
| GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Jul 02, 2018 | Option Exercise | $15.47 | 1,010 | 15,625 | 1,928,783 | Jul 03, 2018, 11:06 AM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Jul 02, 2018 | Option Exercise | $15.47 | 808 | 12,500 | 13,891 | Jul 03, 2018, 11:05 AM | |
| GTXI | GTX INC /DE/ | Wills Robert James | Executive Chairman | Jun 26, 2018 | Buy | $16.75 | 5,000 | 83,750 | 137,344 | Jun 26, 2018, 11:21 AM | |
| GTXI | GTX INC /DE/ | DOGGRELL HENRY PATTON | VP, Chief Legal Officer | Jun 20, 2018 | Sale | $19.01 | 7,351 | 139,708 | 43,630 | Jun 22, 2018, 05:16 PM | |
| GTXI | GTX INC /DE/ | Shackelford Jason T | Prin Fin. & Acct. Officer | Jun 20, 2018 | Sale | $19.01 | 9,279 | 176,350 | 19,453 | Jun 22, 2018, 05:15 PM | |
| GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Apr 02, 2018 | Option Exercise | $17.47 | 894 | 15,618 | 1,927,773 | Apr 03, 2018, 04:47 PM | |
| GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Apr 02, 2018 | Option Exercise | $17.47 | 766 | 13,382 | 34,324 | Apr 03, 2018, 04:47 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Apr 02, 2018 | Option Exercise | $17.47 | 716 | 12,509 | 13,083 | Apr 03, 2018, 04:46 PM | |
| GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Officer | Jan 05, 2018 | Sale | $11.33 | 7,309 | 82,845 | 129,990 | Jan 09, 2018, 06:12 PM | |
| GTXI | GTX INC /DE/ | Shackelford Jason T | Prin Fin. & Acct. Officer | Jan 05, 2018 | Sale | $11.33 | 3,090 | 35,024 | 31,111 | Jan 09, 2018, 06:12 PM | |
| GTXI | GTX INC /DE/ | DOGGRELL HENRY PATTON | VP, Chief Legal Officer | Jan 05, 2018 | Sale | $11.33 | 4,965 | 56,277 | 54,804 | Jan 09, 2018, 06:11 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Jan 02, 2018 | Option Exercise | $11.46 | 1,091 | 12,503 | 12,367 | Jan 04, 2018, 12:40 PM | |
| GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Jan 02, 2018 | Option Exercise | $11.46 | 1,363 | 15,620 | 1,734,893 | Jan 04, 2018, 12:39 PM | |
| GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Jan 02, 2018 | Option Exercise | $11.46 | 1,167 | 13,374 | 33,558 | Jan 04, 2018, 12:39 PM | |
| GTXI | GTX INC /DE/ | Shackelford Jason T | Prin Fin. & Acct. Officer | Jan 01, 2018 | Option Exercise | $12.71 | 2,704 | 34,368 | 31,822 | Jan 03, 2018, 06:25 PM | |
| GTXI | GTX INC /DE/ | DOGGRELL HENRY PATTON | VP, Chief Legal Officer | Jan 01, 2018 | Option Exercise | $12.71 | 4,345 | 55,225 | 55,946 | Jan 03, 2018, 06:24 PM | |
| GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Officer | Jan 01, 2018 | Option Exercise | $12.71 | 6,397 | 81,306 | 131,671 | Jan 03, 2018, 06:24 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Oct 02, 2017 | Option Exercise | $7.94 | 1,574 | 12,498 | 11,277 | Oct 04, 2017, 04:06 PM | |
| GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Oct 02, 2017 | Option Exercise | $7.94 | 1,685 | 13,379 | 32,391 | Oct 04, 2017, 04:06 PM | |
| GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Oct 02, 2017 | Option Exercise | $7.94 | 1,968 | 15,626 | 3,983,530 | Oct 04, 2017, 04:05 PM | |
| GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Jul 03, 2017 | Option Exercise | $5.26 | 2,543 | 13,376 | 30,707 | Jul 05, 2017, 12:00 AM | |
| GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Jul 03, 2017 | Option Exercise | $5.26 | 2,971 | 15,627 | 2,828,265 | Jul 05, 2017, 12:00 AM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Jul 03, 2017 | Option Exercise | $5.26 | 2,376 | 12,498 | 9,702 | Jul 05, 2017, 12:00 AM | |
| GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Apr 03, 2017 | Option Exercise | $4.90 | 3,189 | 15,626 | 2,075,287 | Apr 05, 2017, 04:59 PM | |
| GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Apr 03, 2017 | Option Exercise | $4.90 | 2,730 | 13,377 | 28,164 | Apr 05, 2017, 04:58 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Apr 03, 2017 | Option Exercise | $4.90 | 2,551 | 12,500 | 7,326 | Apr 05, 2017, 04:58 PM | |
| GTXI | GTX INC /DE/ | Young Diane C. | VP, Chief Medical Officer | Oct 28, 2016 | Sale | $7.70 | 500 | 3,850 | 0 | Feb 28, 2017, 05:16 PM | |
| GTXI | GTX INC /DE/ | ROBINSON KENNETH S | Director | Jan 03, 2017 | Option Exercise | $5.21 | 2,567 | 13,374 | 25,434 | Jan 04, 2017, 05:03 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Jan 03, 2017 | Option Exercise | $5.21 | 2,399 | 12,499 | 4,775 | Jan 04, 2017, 05:03 PM | |
| GTXI | GTX INC /DE/ | Pyramid Peak Foundation | 10% Owner | Oct 14, 2016 | Buy | $0.81 | 7,716,049 | 6,250,000 | 38,249,528 | Oct 17, 2016, 05:10 PM | |
| GTXI | GTX INC /DE/ | HYDE JOSEPH R III | Director | Oct 14, 2016 | Option Exercise | $0.81 | 7,716,049 | 6,250,000 | 43,191,009 | Oct 17, 2016, 04:17 PM | |
| GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Officer | Oct 14, 2016 | Option Exercise | $0.81 | 123,456 | 99,999 | 1,380,680 | Oct 17, 2016, 04:17 PM | |
| GTXI | GTX INC /DE/ | Wills Robert James | Executive Chairman | Oct 14, 2016 | Option Exercise | $0.81 | 123,456 | 99,999 | 1,323,456 | Oct 17, 2016, 04:17 PM | |
| GTXI | GTX INC /DE/ | Wills Robert James | Executive Chairman | Jun 16, 2016 | Buy | $0.65 | 100,000 | 65,360 | 1,200,000 | Jun 20, 2016, 10:19 AM | |
| GTXI | GTX INC /DE/ | GLASS J KENNETH | Director | Mar 01, 2016 | Buy | $0.60 | 44,000 | 26,400 | 183,768 | Mar 02, 2016, 05:03 PM | |
| GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Officer | Jan 26, 2016 | Buy | $0.65 | 4,000 | 2,600 | 1,257,224 | Jan 26, 2016, 04:40 PM | |
| GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Officer | Jan 25, 2016 | Buy | $0.63 | 12,813 | 8,067 | 1,253,224 | Jan 25, 2016, 04:40 PM | |
| GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Officer | Jan 19, 2016 | Buy | $0.50 | 25,000 | 12,427 | 1,240,411 | Jan 19, 2016, 05:06 PM | |
| GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Officer | Jan 14, 2016 | Buy | $0.47 | 2,900 | 1,377 | 1,193,311 | Jan 15, 2016, 01:59 PM | |
| GTXI | GTX INC /DE/ | HANOVER MARC STEVEN | Chief Executive Officer | Jan 15, 2016 | Buy | $0.49 | 22,100 | 10,889 | 1,215,411 | Jan 15, 2016, 01:59 PM | |
| GTXI | GTX INC /DE/ | GLASS J KENNETH | Director | Dec 24, 2015 | Buy | $0.79 | 100 | 79 | 139,768 | Dec 28, 2015, 05:07 PM |
Menu